Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 25/07/20181 min de leitura
Facilitating Competition and Innovation in the Biological Products Marketplace; Public Hearing; Request for Comments
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA or the Agency) is announcing a public hearing on FDA's approach to enhancing competition and innovation in the biological products marketplace, including by facilitating greater availability of biosimilar and interchangeable products.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →